| Pseudohyperphosphatemia. | |
| | |
MedLine Citation:
|
PMID: 8521592 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To review instances of spurious elevation of inorganic phosphate measurements due to interference with analytical methods. METHODS: SElective literature review. RESULTS: Depending on the method used to measure inorganic phosphate, several factors have been reported to produce spurious elevations, including paraproteinemia, hyperlipidemia, hemolysis, and hyperbilirubinemia. Of these, paraproteinemia is probably the commonest. CONCLUSION: Both clinical biochemists and clinicians should be aware of the phenomenon of pseudohyperphosphatemia. Clinically unexplained persistent hyperphosphatemia should initiate a search for potential causes of pseudohypophosphatemia, especially paraproteinemia. |
| | |
Authors:
|
A J Larner |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Clinical biochemistry Volume: 28 ISSN: 0009-9120 ISO Abbreviation: Clin. Biochem. Publication Date: 1995 Aug |
Date Detail:
|
Created Date: 1996-01-24 Completed Date: 1996-01-24 Revised Date: 2009-09-29 |
Medline Journal Info:
|
Nlm Unique ID: 0133660 Medline TA: Clin Biochem Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 391-3 Citation Subset: IM |
Affiliation:
|
University of Cambridge Department of Anatomy, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Chemical Analysis
/
methods* False Positive Reactions Humans Phosphates / blood* |
| Grant Support | |
ID/Acronym/Agency:
|
//Wellcome Trust |
| Chemical | |
Reg. No./Substance:
|
0/Phosphates |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Screening for cancer in high risk families.
Next Document: Development of an enzyme-linked immunosorbent assay for 2,3-dinor-6-keto-prostaglandin F1 alpha in u...